Literature DB >> 15285979

Low-dose cortisol for symptoms of posttraumatic stress disorder.

Amanda Aerni1, Rafael Traber, Christoph Hock, Benno Roozendaal, Gustav Schelling, Andreas Papassotiropoulos, Roger M Nitsch, Ulrich Schnyder, Dominique J-F de Quervain.   

Abstract

OBJECTIVE: Because elevated cortisol levels inhibit memory retrieval in healthy human subjects, the present study investigated whether cortisol administration might also reduce excessive retrieval of traumatic memories and related symptoms in patients with chronic posttraumatic stress disorder (PTSD).
METHOD: During a 3-month observation period, low-dose cortisol (10 mg/day) was administered orally for 1 month to three patients with chronic PTSD in a double-blind, placebo-controlled, crossover design.
RESULTS: In each patient investigated, there was a significant treatment effect, with cortisol-related reductions of at least 38% in one of the daily rated symptoms of traumatic memories, as assessed by self-administered rating scales. In accordance, Clinician-Administered PTSD Scale ratings assessed after each month showed cortisol-related improvements for reexperiencing symptoms and, additionally, in one patient for avoidance symptoms.
CONCLUSIONS: The results of this pilot study indicate that low-dose cortisol treatment reduces the cardinal symptoms of PTSD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15285979     DOI: 10.1176/appi.ajp.161.8.1488

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  84 in total

Review 1.  Molecular specificity of multiple hippocampal processes governing fear extinction.

Authors:  Jelena Radulovic; Natalie C Tronson
Journal:  Rev Neurosci       Date:  2010       Impact factor: 4.353

2.  Best practice guide for the treatment of nightmare disorder in adults.

Authors:  R Nisha Aurora; Rochelle S Zak; Sanford H Auerbach; Kenneth R Casey; Susmita Chowdhuri; Anoop Karippot; Rama K Maganti; Kannan Ramar; David A Kristo; Sabin R Bista; Carin I Lamm; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

3.  Postreactivation glucocorticoids impair recall of established fear memory.

Authors:  Wen-Hui Cai; Jacqueline Blundell; Jie Han; Robert W Greene; Craig M Powell
Journal:  J Neurosci       Date:  2006-09-13       Impact factor: 6.167

4.  Healing anxiety disorders with glucocorticoids.

Authors:  Carmen Sandi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

5.  Acute hydrocortisone treatment increases anxiety but not fear in healthy volunteers: a fear-potentiated startle study.

Authors:  Christian Grillon; Randi Heller; Elizabeth Hirschhorn; Mitchel A Kling; Daniel S Pine; Jay Schulkin; Meena Vythilingam
Journal:  Biol Psychiatry       Date:  2011-01-31       Impact factor: 13.382

Review 6.  Stress, glucocorticoids and memory: implications for treating fear-related disorders.

Authors:  Dominique de Quervain; Lars Schwabe; Benno Roozendaal
Journal:  Nat Rev Neurosci       Date:  2016-11-24       Impact factor: 34.870

Review 7.  [Targeted prevention of posttraumatic stress disorder].

Authors:  J Hellmann; I Heuser; G Kronenberg
Journal:  Nervenarzt       Date:  2011-07       Impact factor: 1.214

Review 8.  Pharmacological treatment of PTSD - established and new approaches.

Authors:  Thomas Steckler; Victoria Risbrough
Journal:  Neuropharmacology       Date:  2011-06-29       Impact factor: 5.250

Review 9.  From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders.

Authors:  Michael B VanElzakker; M Kathryn Dahlgren; F Caroline Davis; Stacey Dubois; Lisa M Shin
Journal:  Neurobiol Learn Mem       Date:  2013-12-07       Impact factor: 2.877

10.  Exogenous cortisol acutely influences motivated decision making in healthy young men.

Authors:  Peter Putman; Niki Antypa; Panagiota Crysovergi; Willem A J van der Does
Journal:  Psychopharmacology (Berl)       Date:  2009-12-02       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.